Sit down with Peter Fecci, MD, PhD, from the Preston Robert Tisch Brain Tumor Center on this week’s episode of the Immunology Podcast, as he talks about his lab’s work in activating T cells to target brain tumors.
Dr. Fecci’s work primarily focuses on the programmatic interests on the design, optimization, and monitoring of immune-based treatment platforms for patients with intracranial tumors, whether primary or metastatic. His ultimate goal is to unify brain tumor research and clinical care, fostering a cohesive collaboration among researchers, neuro-oncologists, medical oncologists, radiation oncologists, biomedical engineers, and neurosurgeons, ensuring that science and treatment work hand in hand as the standard of care.
To listen to the full podcast episode, visit: https://www.immunologypodcast.com/ep-64-brain-tumor-immunotherapy-featuring-dr-peter-fecci
To learn more about Dr. Fecci’s clinical work, visit: https://www.dukehealth.org/find-doctors-physicians/peter-e-fecci-md-phd